InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.9%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by STARR CHRISTOPHER M, Director. Insider active across 1 company, notably Monopar Therapeutics. Cumulatively, 14 disclosures have been logged. Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
2,533 sharesCommon StockSEC:0001437749-24-000483:0
2,533 sharesCommon StockSEC:0001437749-23-027586:0
2,534 sharesCommon StockSEC:0001437749-23-019259:0
2,533 sharesCommon StockSEC:0001437749-23-009337:0
2,859 sharesCommon StockSEC:0001437749-23-000170:0
2,859 sharesCommon StockSEC:0001654954-22-013281:0
2,859 sharesCommon StockSEC:0001654954-22-009137:0
2,859 sharesCommon StockSEC:0001654954-22-004480:0
751 sharesCommon StockSEC:0001654954-22-000118
751 sharesCommon StockSEC:0001654954-22-000118:0
751 sharesCommon StockSEC:0001654954-21-010718:0
751 sharesCommon StockSEC:0001654954-21-010718
752 sharesCommon StockSEC:0001654954-21-007605:0
752 sharesCommon StockSEC:0001654954-21-007605
14 of 14 declarations
About STARR CHRISTOPHER M
Christopher M. Starr is a Board Member at Monopar Therapeutics. He brings expertise in corporate governance and investment strategy. As a board member, he plays a key role in guiding strategic decisions and overseeing the company's performance. His experience in the biopharmaceutical sector is a valuable asset.
